Advertisement

Index by author

August 01, 1991; Volume 40,Issue 2

B

  1. Barber, R

    1. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
      D Stickle and R Barber
      Molecular Pharmacology August 1991, 40 (2) 276-288;

  2. Bauer, P H

    1. Inhibitory GTP-binding regulatory protein Gi3 can couple angiotensin II receptors to inhibition of adenylyl cyclase in hepatocytes.
      B F Pobiner, J K Northup, P H Bauer, E D Fraser and J C Garrison
      Molecular Pharmacology August 1991, 40 (2) 156-167;

  3. Bird, G S

    1. Role of inositol (1,4,5)trisphosphate in epidermal growth factor-induced Ca2+ signaling in A431 cells.
      A R Hughes, G S Bird, J F Obie, O Thastrup and J W Putney
      Molecular Pharmacology August 1991, 40 (2) 254-262;

  4. Bornheim, L M

    1. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily.
      L M Bornheim and M A Correia
      Molecular Pharmacology August 1991, 40 (2) 228-234;

  5. Brann, M R

    1. Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells.
      S V Jones, C J Heilman and M R Brann
      Molecular Pharmacology August 1991, 40 (2) 242-247;

  6. Brovtsina, N

    1. Effect of (+)-sparteine on nicotinic acetylcholine receptors in the neurons of rat superior cervical ganglion.
      S Voitenko, S Purnyn, I Omeltchenko, G G Dyadyusha, B Zhorov, N Brovtsina and V Skok
      Molecular Pharmacology August 1991, 40 (2) 180-185;

  7. Brown, A M

    1. Patterns of internal and external tetraethylammonium block in four homologous K+ channels.
      M Taglialatela, A M Vandongen, J A Drewe, R H Joho, A M Brown and G E Kirsch
      Molecular Pharmacology August 1991, 40 (2) 299-307;

  8. Buck, M A

    1. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
      C D Wang, M A Buck and C M Fraser
      Molecular Pharmacology August 1991, 40 (2) 168-179;

  9. Bylund, D B

    1. Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland.
      V Simonneaux, M Ebadi and D B Bylund
      Molecular Pharmacology August 1991, 40 (2) 235-241;

C

  1. Carlson, C D

    1. Stimulation of tyrosine hydroxylase gene transcription rate by nicotine in rat adrenal medulla.
      L H Fossom, C D Carlson and A W Tank
      Molecular Pharmacology August 1991, 40 (2) 193-202;

  2. Colby, H D

    1. Role of the steroid 17 alpha-hydroxylase in spironolactone-mediated destruction of adrenal cytochrome P-450.
      D C Kossor, S Kominami, S Takemori and H D Colby
      Molecular Pharmacology August 1991, 40 (2) 321-325;

  3. Correia, M A

    1. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily.
      L M Bornheim and M A Correia
      Molecular Pharmacology August 1991, 40 (2) 228-234;

  4. Costa, E

    1. Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes.
      X Vigé, E Costa and B C Wise
      Molecular Pharmacology August 1991, 40 (2) 186-192;

  5. Cresteil, T

    1. Hormonal regulation of microsomal flavin-containing monooxygenase: tissue-dependent expression and substrate specificity.
      A Lemoine, D E Williams, T Cresteil and J P Leroux
      Molecular Pharmacology August 1991, 40 (2) 211-217;

  6. Cully, D F

    1. Solubilization and characterization of a high affinity ivermectin binding site from Caenorhabditis elegans.
      D F Cully and P S Paress
      Molecular Pharmacology August 1991, 40 (2) 326-332;

D

  1. Dazin, P F

    1. Agonistic activities of histamine-albumin conjugates at histamine H2 receptors on human HL-60 promyelocytic leukemia cells.
      M Mitsuhashi, T Mitsuhashi, P F Dazin and D G Payan
      Molecular Pharmacology August 1991, 40 (2) 271-275;

  2. Dichter, M

    1. Subtypes of brain somatostatin receptors couple to multiple cellular effector systems.
      K Raynor, H L Wang, M Dichter and T Reisine
      Molecular Pharmacology August 1991, 40 (2) 248-253;

  3. Drewe, J A

    1. Patterns of internal and external tetraethylammonium block in four homologous K+ channels.
      M Taglialatela, A M Vandongen, J A Drewe, R H Joho, A M Brown and G E Kirsch
      Molecular Pharmacology August 1991, 40 (2) 299-307;

  4. Dyadyusha, G G

    1. Effect of (+)-sparteine on nicotinic acetylcholine receptors in the neurons of rat superior cervical ganglion.
      S Voitenko, S Purnyn, I Omeltchenko, G G Dyadyusha, B Zhorov, N Brovtsina and V Skok
      Molecular Pharmacology August 1991, 40 (2) 180-185;

E

  1. Ebadi, M

    1. Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland.
      V Simonneaux, M Ebadi and D B Bylund
      Molecular Pharmacology August 1991, 40 (2) 235-241;

F

  1. Fossom, L H

    1. Stimulation of tyrosine hydroxylase gene transcription rate by nicotine in rat adrenal medulla.
      L H Fossom, C D Carlson and A W Tank
      Molecular Pharmacology August 1991, 40 (2) 193-202;

  2. Fraser, C M

    1. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
      C D Wang, M A Buck and C M Fraser
      Molecular Pharmacology August 1991, 40 (2) 168-179;

  3. Fraser, E D

    1. Inhibitory GTP-binding regulatory protein Gi3 can couple angiotensin II receptors to inhibition of adenylyl cyclase in hepatocytes.
      B F Pobiner, J K Northup, P H Bauer, E D Fraser and J C Garrison
      Molecular Pharmacology August 1991, 40 (2) 156-167;

  4. Fredholm, B B

    1. Glucocorticoid receptor activation leads to up-regulation of adenosine A1 receptors and down-regulation of adenosine A2 responses in DDT1 MF-2 smooth muscle cells.
      P Gerwins and B B Fredholm
      Molecular Pharmacology August 1991, 40 (2) 149-155;

G

  1. Garrison, J C

    1. Inhibitory GTP-binding regulatory protein Gi3 can couple angiotensin II receptors to inhibition of adenylyl cyclase in hepatocytes.
      B F Pobiner, J K Northup, P H Bauer, E D Fraser and J C Garrison
      Molecular Pharmacology August 1991, 40 (2) 156-167;

  2. Gerwins, P

    1. Glucocorticoid receptor activation leads to up-regulation of adenosine A1 receptors and down-regulation of adenosine A2 responses in DDT1 MF-2 smooth muscle cells.
      P Gerwins and B B Fredholm
      Molecular Pharmacology August 1991, 40 (2) 149-155;

  3. Guzelian, P S

    1. Selective induction of cytochrome P450e by kepone (chlordecone) in primary cultures of adult rat hepatocytes.
      T A Kocarek, E G Schuetz and P S Guzelian
      Molecular Pharmacology August 1991, 40 (2) 203-210;

H

  1. Hamblin, M W

    1. Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
      M W Hamblin and M A Metcalf
      Molecular Pharmacology August 1991, 40 (2) 143-148;

  2. Heilman, C J

    1. Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells.
      S V Jones, C J Heilman and M R Brann
      Molecular Pharmacology August 1991, 40 (2) 242-247;

  3. Hughes, A R

    1. Role of inositol (1,4,5)trisphosphate in epidermal growth factor-induced Ca2+ signaling in A431 cells.
      A R Hughes, G S Bird, J F Obie, O Thastrup and J W Putney
      Molecular Pharmacology August 1991, 40 (2) 254-262;

J

  1. Joho, R H

    1. Patterns of internal and external tetraethylammonium block in four homologous K+ channels.
      M Taglialatela, A M Vandongen, J A Drewe, R H Joho, A M Brown and G E Kirsch
      Molecular Pharmacology August 1991, 40 (2) 299-307;

  2. Jones, S V

    1. Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells.
      S V Jones, C J Heilman and M R Brann
      Molecular Pharmacology August 1991, 40 (2) 242-247;

K

  1. Kirsch, G E

    1. Patterns of internal and external tetraethylammonium block in four homologous K+ channels.
      M Taglialatela, A M Vandongen, J A Drewe, R H Joho, A M Brown and G E Kirsch
      Molecular Pharmacology August 1991, 40 (2) 299-307;

  2. Kocarek, T A

    1. Selective induction of cytochrome P450e by kepone (chlordecone) in primary cultures of adult rat hepatocytes.
      T A Kocarek, E G Schuetz and P S Guzelian
      Molecular Pharmacology August 1991, 40 (2) 203-210;

  3. Kominami, S

    1. Role of the steroid 17 alpha-hydroxylase in spironolactone-mediated destruction of adrenal cytochrome P-450.
      D C Kossor, S Kominami, S Takemori and H D Colby
      Molecular Pharmacology August 1991, 40 (2) 321-325;

  4. Kossor, D C

    1. Role of the steroid 17 alpha-hydroxylase in spironolactone-mediated destruction of adrenal cytochrome P-450.
      D C Kossor, S Kominami, S Takemori and H D Colby
      Molecular Pharmacology August 1991, 40 (2) 321-325;

L

  1. Legendre, P

    1. Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism.
      P Legendre and G L Westbrook
      Molecular Pharmacology August 1991, 40 (2) 289-298;

  2. Lemoine, A

    1. Hormonal regulation of microsomal flavin-containing monooxygenase: tissue-dependent expression and substrate specificity.
      A Lemoine, D E Williams, T Cresteil and J P Leroux
      Molecular Pharmacology August 1991, 40 (2) 211-217;

  3. Leroux, J P

    1. Hormonal regulation of microsomal flavin-containing monooxygenase: tissue-dependent expression and substrate specificity.
      A Lemoine, D E Williams, T Cresteil and J P Leroux
      Molecular Pharmacology August 1991, 40 (2) 211-217;

  4. Lovinger, D M

    1. Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons.
      D M Lovinger and G White
      Molecular Pharmacology August 1991, 40 (2) 263-270;

M

  1. Martell, K J

    1. Molecular genetic basis of rapid and slow acetylation in mice.
      K J Martell, K P Vatsis and W W Weber
      Molecular Pharmacology August 1991, 40 (2) 218-227;

  2. Meerman, J H

    1. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
      D Noort, E A Meijer, T J Visser, J H Meerman, G A Van der Marel, J H Van Boom and G J Mulder
      Molecular Pharmacology August 1991, 40 (2) 316-320;

  3. Meijer, E A

    1. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
      D Noort, E A Meijer, T J Visser, J H Meerman, G A Van der Marel, J H Van Boom and G J Mulder
      Molecular Pharmacology August 1991, 40 (2) 316-320;

  4. Metcalf, M A

    1. Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
      M W Hamblin and M A Metcalf
      Molecular Pharmacology August 1991, 40 (2) 143-148;

  5. Mitsuhashi, M

    1. Agonistic activities of histamine-albumin conjugates at histamine H2 receptors on human HL-60 promyelocytic leukemia cells.
      M Mitsuhashi, T Mitsuhashi, P F Dazin and D G Payan
      Molecular Pharmacology August 1991, 40 (2) 271-275;

  6. Mitsuhashi, T

    1. Agonistic activities of histamine-albumin conjugates at histamine H2 receptors on human HL-60 promyelocytic leukemia cells.
      M Mitsuhashi, T Mitsuhashi, P F Dazin and D G Payan
      Molecular Pharmacology August 1991, 40 (2) 271-275;

  7. Mulder, G J

    1. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
      D Noort, E A Meijer, T J Visser, J H Meerman, G A Van der Marel, J H Van Boom and G J Mulder
      Molecular Pharmacology August 1991, 40 (2) 316-320;

N

  1. Noort, D

    1. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
      D Noort, E A Meijer, T J Visser, J H Meerman, G A Van der Marel, J H Van Boom and G J Mulder
      Molecular Pharmacology August 1991, 40 (2) 316-320;

  2. Northup, J K

    1. Inhibitory GTP-binding regulatory protein Gi3 can couple angiotensin II receptors to inhibition of adenylyl cyclase in hepatocytes.
      B F Pobiner, J K Northup, P H Bauer, E D Fraser and J C Garrison
      Molecular Pharmacology August 1991, 40 (2) 156-167;

O

  1. Obie, J F

    1. Role of inositol (1,4,5)trisphosphate in epidermal growth factor-induced Ca2+ signaling in A431 cells.
      A R Hughes, G S Bird, J F Obie, O Thastrup and J W Putney
      Molecular Pharmacology August 1991, 40 (2) 254-262;

  2. Omeltchenko, I

    1. Effect of (+)-sparteine on nicotinic acetylcholine receptors in the neurons of rat superior cervical ganglion.
      S Voitenko, S Purnyn, I Omeltchenko, G G Dyadyusha, B Zhorov, N Brovtsina and V Skok
      Molecular Pharmacology August 1991, 40 (2) 180-185;

P

  1. Paress, P S

    1. Solubilization and characterization of a high affinity ivermectin binding site from Caenorhabditis elegans.
      D F Cully and P S Paress
      Molecular Pharmacology August 1991, 40 (2) 326-332;

  2. Payan, D G

    1. Agonistic activities of histamine-albumin conjugates at histamine H2 receptors on human HL-60 promyelocytic leukemia cells.
      M Mitsuhashi, T Mitsuhashi, P F Dazin and D G Payan
      Molecular Pharmacology August 1991, 40 (2) 271-275;

  3. Pobiner, B F

    1. Inhibitory GTP-binding regulatory protein Gi3 can couple angiotensin II receptors to inhibition of adenylyl cyclase in hepatocytes.
      B F Pobiner, J K Northup, P H Bauer, E D Fraser and J C Garrison
      Molecular Pharmacology August 1991, 40 (2) 156-167;

  4. Politi, D M

    1. Glyburide-sensitive K+ channels in cultured rat hippocampal neurons: activation by cromakalim and energy-depleting conditions.
      D M Politi and M A Rogawski
      Molecular Pharmacology August 1991, 40 (2) 308-315;

  5. Purnyn, S

    1. Effect of (+)-sparteine on nicotinic acetylcholine receptors in the neurons of rat superior cervical ganglion.
      S Voitenko, S Purnyn, I Omeltchenko, G G Dyadyusha, B Zhorov, N Brovtsina and V Skok
      Molecular Pharmacology August 1991, 40 (2) 180-185;

  6. Putney, J W

    1. Role of inositol (1,4,5)trisphosphate in epidermal growth factor-induced Ca2+ signaling in A431 cells.
      A R Hughes, G S Bird, J F Obie, O Thastrup and J W Putney
      Molecular Pharmacology August 1991, 40 (2) 254-262;

R

  1. Raynor, K

    1. Subtypes of brain somatostatin receptors couple to multiple cellular effector systems.
      K Raynor, H L Wang, M Dichter and T Reisine
      Molecular Pharmacology August 1991, 40 (2) 248-253;

  2. Reisine, T

    1. Subtypes of brain somatostatin receptors couple to multiple cellular effector systems.
      K Raynor, H L Wang, M Dichter and T Reisine
      Molecular Pharmacology August 1991, 40 (2) 248-253;

  3. Rogawski, M A

    1. Glyburide-sensitive K+ channels in cultured rat hippocampal neurons: activation by cromakalim and energy-depleting conditions.
      D M Politi and M A Rogawski
      Molecular Pharmacology August 1991, 40 (2) 308-315;

S

  1. Schuetz, E G

    1. Selective induction of cytochrome P450e by kepone (chlordecone) in primary cultures of adult rat hepatocytes.
      T A Kocarek, E G Schuetz and P S Guzelian
      Molecular Pharmacology August 1991, 40 (2) 203-210;

  2. Simonneaux, V

    1. Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland.
      V Simonneaux, M Ebadi and D B Bylund
      Molecular Pharmacology August 1991, 40 (2) 235-241;

  3. Skok, V

    1. Effect of (+)-sparteine on nicotinic acetylcholine receptors in the neurons of rat superior cervical ganglion.
      S Voitenko, S Purnyn, I Omeltchenko, G G Dyadyusha, B Zhorov, N Brovtsina and V Skok
      Molecular Pharmacology August 1991, 40 (2) 180-185;

  4. Stickle, D

    1. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
      D Stickle and R Barber
      Molecular Pharmacology August 1991, 40 (2) 276-288;

T

  1. Taglialatela, M

    1. Patterns of internal and external tetraethylammonium block in four homologous K+ channels.
      M Taglialatela, A M Vandongen, J A Drewe, R H Joho, A M Brown and G E Kirsch
      Molecular Pharmacology August 1991, 40 (2) 299-307;

  2. Takemori, S

    1. Role of the steroid 17 alpha-hydroxylase in spironolactone-mediated destruction of adrenal cytochrome P-450.
      D C Kossor, S Kominami, S Takemori and H D Colby
      Molecular Pharmacology August 1991, 40 (2) 321-325;

  3. Tank, A W

    1. Stimulation of tyrosine hydroxylase gene transcription rate by nicotine in rat adrenal medulla.
      L H Fossom, C D Carlson and A W Tank
      Molecular Pharmacology August 1991, 40 (2) 193-202;

  4. Thastrup, O

    1. Role of inositol (1,4,5)trisphosphate in epidermal growth factor-induced Ca2+ signaling in A431 cells.
      A R Hughes, G S Bird, J F Obie, O Thastrup and J W Putney
      Molecular Pharmacology August 1991, 40 (2) 254-262;

V

  1. Van Boom, J H

    1. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
      D Noort, E A Meijer, T J Visser, J H Meerman, G A Van der Marel, J H Van Boom and G J Mulder
      Molecular Pharmacology August 1991, 40 (2) 316-320;

  2. Van der Marel, G A

    1. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
      D Noort, E A Meijer, T J Visser, J H Meerman, G A Van der Marel, J H Van Boom and G J Mulder
      Molecular Pharmacology August 1991, 40 (2) 316-320;

  3. Vandongen, A M

    1. Patterns of internal and external tetraethylammonium block in four homologous K+ channels.
      M Taglialatela, A M Vandongen, J A Drewe, R H Joho, A M Brown and G E Kirsch
      Molecular Pharmacology August 1991, 40 (2) 299-307;

  4. Vatsis, K P

    1. Molecular genetic basis of rapid and slow acetylation in mice.
      K J Martell, K P Vatsis and W W Weber
      Molecular Pharmacology August 1991, 40 (2) 218-227;

  5. Vigé, X

    1. Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes.
      X Vigé, E Costa and B C Wise
      Molecular Pharmacology August 1991, 40 (2) 186-192;

  6. Visser, T J

    1. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
      D Noort, E A Meijer, T J Visser, J H Meerman, G A Van der Marel, J H Van Boom and G J Mulder
      Molecular Pharmacology August 1991, 40 (2) 316-320;

  7. Voitenko, S

    1. Effect of (+)-sparteine on nicotinic acetylcholine receptors in the neurons of rat superior cervical ganglion.
      S Voitenko, S Purnyn, I Omeltchenko, G G Dyadyusha, B Zhorov, N Brovtsina and V Skok
      Molecular Pharmacology August 1991, 40 (2) 180-185;

W

  1. Wang, C D

    1. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
      C D Wang, M A Buck and C M Fraser
      Molecular Pharmacology August 1991, 40 (2) 168-179;

  2. Wang, H L

    1. Subtypes of brain somatostatin receptors couple to multiple cellular effector systems.
      K Raynor, H L Wang, M Dichter and T Reisine
      Molecular Pharmacology August 1991, 40 (2) 248-253;

  3. Weber, W W

    1. Molecular genetic basis of rapid and slow acetylation in mice.
      K J Martell, K P Vatsis and W W Weber
      Molecular Pharmacology August 1991, 40 (2) 218-227;

  4. Westbrook, G L

    1. Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism.
      P Legendre and G L Westbrook
      Molecular Pharmacology August 1991, 40 (2) 289-298;

  5. White, G

    1. Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons.
      D M Lovinger and G White
      Molecular Pharmacology August 1991, 40 (2) 263-270;

  6. Williams, D E

    1. Hormonal regulation of microsomal flavin-containing monooxygenase: tissue-dependent expression and substrate specificity.
      A Lemoine, D E Williams, T Cresteil and J P Leroux
      Molecular Pharmacology August 1991, 40 (2) 211-217;

  7. Wise, B C

    1. Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes.
      X Vigé, E Costa and B C Wise
      Molecular Pharmacology August 1991, 40 (2) 186-192;

Z

  1. Zhorov, B

    1. Effect of (+)-sparteine on nicotinic acetylcholine receptors in the neurons of rat superior cervical ganglion.
      S Voitenko, S Purnyn, I Omeltchenko, G G Dyadyusha, B Zhorov, N Brovtsina and V Skok
      Molecular Pharmacology August 1991, 40 (2) 180-185;
Back to top

In this issue